The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 17, 2021
Senhwa Biosciences, Inc., a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, ...
read more
Monday, December 20, 2021
AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients ...
read more
Tuesday, December 21, 2021
The U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and ...
read more
Tuesday, December 21, 2021
The Food and Drug Administration approved the second biosimilar insulin product, Eli Lilly’s Rezvoglar (insulin glargine-aglr). Rezvoglar (insulin ...
read more
Wednesday, December 29, 2021
Sandoz has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150 mg, for intravenous use) developed by EirGenix, ...
read more
Tuesday, January 04, 2022
Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced that the company has closed on a $31 million ...
read more
Tuesday, January 04, 2022
Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced the closing of Gilead’s option exercises to three programs in Arcus’s clinical-stage ...
read more
Wednesday, January 05, 2022
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster...
read more
Thursday, January 06, 2022
TRexBio Inc. has entered into a multi-year research collaboration and licensing agreement with Janssen Pharmaceutica NV, one of the Janssen ...
read more
Absci Corporation has entered into a research collaboration with Merck (known as MSD outside the United States and Canada), using Absci’s AI-powered ...
read more
Rain Therapeutics Inc. announced a clinical supply agreement with Roche for the supply of the anti-Programmed Death Ligand-1 (PD-L1) monoclonal ...
read more
Covis Pharma Group announced that Covis Pharma GmbH has completed the acquisition of Eklira® (aclidinium bromide), known as Tudorza® in the US and ...
read more
Wednesday, January 19, 2022
Endo International announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. have entered into a ...
read more
Wednesday, January 19, 2022
Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, has closed a transaction to acquire the US sales and distribution ...
read more
Lantern Pharma announced that the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation and Orphan Drug ...
read more